🇺🇸 SECGSK plcDoubao · 实盘不做把握 9/10不做原因:标的无直接敞口
北京时间·🕒 发布 23:42:12·⟳ 抓取 23:42:32 +20s·⚡ 决策 10-08 23:43:33 +1m01s·19.0 天前
GSK公告独立董事Wendy Becker将出任Tesco非执行董事，属例行董事职务披露
该6-K只是按英国上市规则披露独立董事的外部兼职，未产生与上市公司证券价格相关的经营、财务、控制权或资本结构变化。
📄 原文GSK plc↗ 原文
----- a2299y.htm ----- 6-K 1 a2299y.htm WENDY BECKER CBE - NEW DIRECTORSHIP a2299y UNITED STATES SECURITIES AND EXCHANG…
不做 GSK plc（GSK.US）
独立董事兼任Tesco非执行董事属于例行合规披露，不影响GSK经营、盈利、控制权或资本结构，无交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
GSK披露Wendy Becker将兼任Tesco非执行董事；这是常规治理和董事职务备案，对GSK及Tesco均无可交易的基本面增量，故不做。
🔎 新鲜度:最早出现 2026-10-08 · 扩散 low · price-in 风险 low ↗
关键理由
- 事项属于独立董事外部兼职的合规披露，不涉及GSK收入、利润、研发、管线或战略变化。
- 非执行董事任命亦不改变Tesco的经营决策机制或财务预期，缺乏短线交易edge。
主要风险
- 若随后出现该任命与董事会控制权、重大战略变动或监管事项相关的新增官方信息，需重新研判。
先例如何影响了这次决策
对本次决策的影响:因事件本身无因果交易敞口，先例面板不会改变AVOID结论。
方向:常规非执行董事外部兼职披露没有明确的正负面交易方向。
涨幅量级:缺乏可量化的公司基本面增量，不以历史价格先例设定止盈止损。
形态:未识别到需要验证的见光死或高开低走模式。
原文全文
展开原文 · 1,585 字
----- a2299y.htm -----
6-K
1
a2299y.htm
WENDY BECKER CBE - NEW DIRECTORSHIP
a2299y
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of October 2026
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
Issued: 8 October 2026, London UK
Wendy Becker CBE – New Directorship
In accordance with UK Listing Rule 6.4.9R(2), GSK plc notes that
Wendy Becker, an independent Non-Executive Director, has been
appointed as a Non-Executive Director of Tesco PLC with effect from
1 November 2026.
V A Whyte
Company Secretary
8 October 2026
About GSK
GSK is a global biopharma company with a purpose to unite science,
technology, and talent to get ahead of disease together. Find out
more at
www.gsk.com
.
Registered in England & Wales:
No.
3888792
Registered Office:
79
New Oxford Street
London
WC1A
1DG
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
GSK plc
(Registrant)
Date: October
08, 2026
By:/s/ VICTORIA
WHYTE
--------------------------
Victoria Whyte
Authorised
Signatory for and on
behalf
of GSK plc
6-K
1
a2299y.htm
WENDY BECKER CBE - NEW DIRECTORSHIP
a2299y
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of October 2026
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
Issued: 8 October 2026, London UK
Wendy Becker CBE – New Directorship
In accordance with UK Listing Rule 6.4.9R(2), GSK plc notes that
Wendy Becker, an independent Non-Executive Director, has been
appointed as a Non-Executive Director of Tesco PLC with effect from
1 November 2026.
V A Whyte
Company Secretary
8 October 2026
About GSK
GSK is a global biopharma company with a purpose to unite science,
technology, and talent to get ahead of disease together. Find out
more at
www.gsk.com
.
Registered in England & Wales:
No.
3888792
Registered Office:
79
New Oxford Street
London
WC1A
1DG
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
GSK plc
(Registrant)
Date: October
08, 2026
By:/s/ VICTORIA
WHYTE
--------------------------
Victoria Whyte
Authorised
Signatory for and on
behalf
of GSK plc
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
f5d483194e· 2026-10-08 23:43 · doubao / doubao-seed-evolving-latest-version · 策略包d5018cb8913f当前